In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions

Journal of Virology

Volumn 82, Issue 14, 2008, Pages 6838-6851

  Sehrawat, Sharvan ^a   Suvas, Susmit ^b   Sarangi, Pranita P ^a   Suryawanshi, Amol ^a   Rouse, Barry T ^a,c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; EYE INFECTION; EYE INFLAMMATION; FEMALE; HERPES SIMPLEX VIRUS; IN VITRO STUDY; IN VIVO STUDY; KERATITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; VIRUS INFECTION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BAGG ALBINO MOUSE; FLOW CYTOMETRY; HERPES SIMPLEX; HERPES SIMPLEX KERATITIS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MOUSE MUTANT; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

SIMPLEXVIRUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11C; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HERPES SIMPLEX; IMMUNOSUPPRESSION; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; SIMPLEXVIRUS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 47049097093     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00697-08     Document Type: Article

References (39)

1. Annacker, O., J. L. Coombes, V. Malmstrom, H. H. Uhlig, T. Bourne, B. Johansson-Lindbom, W. W. Agace, C. M. Parker, and F. Powrie. 2005. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202:1051-1061.
2. + regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177:8338-8347.
3. Benson, M. J., K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204:1765-1774.
4. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
5. + T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood 110:1132-1140.
6. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886.
7. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-1764.
8. + T regulatory cells. J. Immunol. 178:4022-4026.
9. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179:4685-4693.
10. + T cells can represent an exclusive means of immunopathology in a virus infection. Eur. J. Immunol. 29:3674-3682.
11. + T cells accounts for herpetic ocular lesions. Investig. Ophthalmol. Vis. Sci. 41:453-459.
12. Haskins, K., R. Kubo, J. White, M. Pigeon, J. Kappler, and P. Marrack. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157:1149-1169.
13. + regulatory T cells. J. Immunol. 179:3724-3733.
14. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 168:4399-4405.
15. Kim, B., Q. Tang, P. S. Biswas, J. Xu, R. M. Schiffelers, F. Y. Xie, A. M. Ansari, P. V. Scaria, M. C. Woodle, P. Lu, and B. T. Rouse. 2004. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 165:2177-2185.
16. Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8:191-197.
17. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Backstrom, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13:423-431.
18. Le Bras, S., and R. S. Geha. 2006. IPEX and the role of Foxp3 in the development and function of human Tregs. J. Clin. Investig. 116:1473-1475.
19. - single positive T cells. Transplantation 82:953-964.
20. Martinic, M. M., and M. G. von Herrath. 2006. Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity? Eur. J. Immunol. 36:2299-2303.
21. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-260.
22. Niemialtowski, M. G., and B. T. Rouse. 1992. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149:3035-3039.
23. Roncarolo, M. G., and M. Battaglia. 2007. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7:585-598.
24. Rouse, B. T. 2007. Regulatory T cells in health and disease. J. Intern. Med. 262:78-95.
25. Selvaraj, R. K., and T. L. Geiger. 2007. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 178:7667-7677.
26. Sharma, M. D., B. Baban, P. Chandler, D. Y. Hou, N. Singh, H. Yagita, M. Azuma, B. R. Blazar, A. L. Mellor, and D. H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Investig. 117:2570-2582.
27. Shevach, E. M. 2006. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25:195-201.
28. Sun, C. M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775-1785.
29. + regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172:4123-4132.
30. + T cell responses. J. Exp. Med. 198:889-901.
31. Tang, Q., and J. A. Bluestone. 2006. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212:217-237.
32. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204:191-201.
33. + T cell function between euthymic host and reconstituted SCID recipients. J. Immunol. 160:3965-3970.
34. + T cell suppressor function. J. Immunol. 172:6519-6523.
35. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
36. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183-190.
37. + regulatory T cells from human peripheral blood. J. Immunol. 166:7282-7289.
38. + regulatory T cells from peripheral Foxp3 precursors. Blood 110:4293-4302.
39. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-226.